Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001415889-22-001225

EVP, CHIEF BUSINESS OFFICER acquired 37,593 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Eaton Bruce EVP, CHIEF BUSINESS OFFICER 2022-02-10 Grant or award +37,593 68,789 D
Derivatives
Eaton Bruce EVP, CHIEF BUSINESS OFFICER 2022-02-10 Grant or award · Stock Option (right to buy) +110,732 110,732 D
Loading xslF345X03/form4-02112022_010246.xml…